GED-0507 is a novel potential antifibrotic treatment option for pulmonary fibrosis – Nographarma

GED-0507 is a novel potential antifibrotic treatment option for pulmonary fibrosis

https://doi.org/10.1038/s41423-020-0394-y

Latest Publications

Smad7 as a positive regulator of intestinal inflammatory diseases

Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials

Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells